November 21, 2011 (San Francisco, California) — Patients with hepatitis C virus infection who failed interferon treatment showed no symptom improvement or slowing of disease progression with the ...
Hanmi Pharmaceutical has relaunched its liver function drug after using its microemulsion technology to improve the absorption rate, thereby addressing a limitation of the original formulation.
In a survey of patients with chronic hepatitis C who participated in a long-term treatment trial for patients who had failed to respond previously to antiviral therapy, approximately 40 percent ...
Silymarin is not soluble in water and is usually administered in capsules as a standard extract (70 to 80% silymarin). Silibinin and other components of silymarin are rapidly conjugated with sulfate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results